FI965008A - Sammansättningar och förfaranden för tumörbehandling - Google Patents

Sammansättningar och förfaranden för tumörbehandling Download PDF

Info

Publication number
FI965008A
FI965008A FI965008A FI965008A FI965008A FI 965008 A FI965008 A FI 965008A FI 965008 A FI965008 A FI 965008A FI 965008 A FI965008 A FI 965008A FI 965008 A FI965008 A FI 965008A
Authority
FI
Finland
Prior art keywords
compositions
methods
treating tumors
tumors
treating
Prior art date
Application number
FI965008A
Other languages
English (en)
Finnish (fi)
Other versions
FI965008A0 (sv
FI119677B (sv
Inventor
Gordon A Vehar
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of FI965008A0 publication Critical patent/FI965008A0/sv
Publication of FI965008A publication Critical patent/FI965008A/sv
Application granted granted Critical
Publication of FI119677B publication Critical patent/FI119677B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI965008A 1994-06-16 1996-12-13 Användning av prokoagulant och cytokin FI119677B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US26085094A 1994-06-16 1994-06-16
US26085094 1994-06-16
PCT/US1995/007305 WO1995034319A1 (en) 1994-06-16 1995-06-08 Compositions and methods for the treatment of tumors
US9507305 1995-06-08

Publications (3)

Publication Number Publication Date
FI965008A0 FI965008A0 (sv) 1996-12-13
FI965008A true FI965008A (sv) 1996-12-13
FI119677B FI119677B (sv) 2009-02-13

Family

ID=22990887

Family Applications (1)

Application Number Title Priority Date Filing Date
FI965008A FI119677B (sv) 1994-06-16 1996-12-13 Användning av prokoagulant och cytokin

Country Status (11)

Country Link
US (2) US5830448A (sv)
EP (1) EP0765168B1 (sv)
JP (1) JPH10501813A (sv)
KR (1) KR970703783A (sv)
AU (1) AU696003B2 (sv)
CA (1) CA2191065A1 (sv)
DE (1) DE69524093T2 (sv)
FI (1) FI119677B (sv)
IL (1) IL114119A (sv)
WO (1) WO1995034319A1 (sv)
ZA (1) ZA954984B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749853B1 (en) * 1992-03-05 2004-06-15 Board Of Regents, The University Of Texas System Combined methods and compositions for coagulation and tumor treatment
US5965132A (en) 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
BR9806793A (pt) 1997-01-22 2000-05-16 Univ Texas Processos e composições de fator tissular para coagulação e tratamento de tumores.
WO1999040929A1 (en) * 1998-02-12 1999-08-19 The General Hospital Corporation Methods to potentiate cancer therapies
US6719977B1 (en) 1998-02-12 2004-04-13 The General Hospital Corporation Methods to potentiate cancer therapies
ATE355029T1 (de) * 1998-04-01 2006-03-15 Univ Columbia Verfahren zur thrombosehemmung bei patienten deren blut extrakorporaler zirkulation ausgesetzt ist
JP2002520297A (ja) * 1998-07-13 2002-07-09 ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム アミノリン脂質に結合する治療結合体を用いる癌処置方法
US6818213B1 (en) * 1998-07-13 2004-11-16 Board Of Regents, The University Of Texas System Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
IL140701A0 (en) * 1998-07-13 2002-02-10 Univ Texas Cancer treatment methods using antibodies to aminophospholipids
US6406693B1 (en) 1998-07-13 2002-06-18 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids
US20030211075A1 (en) * 2001-09-27 2003-11-13 Thorpe Philip E. Combined compositions for tumor vasculature coagulation and treatment
US20050013801A1 (en) * 2001-10-05 2005-01-20 Hsu Henry H. Methods of treating liver fibrosis and hepatitis c virus infection
AU2005313971B2 (en) * 2004-12-08 2011-10-13 Immunomedics, Inc. Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer
WO2012160031A1 (en) 2011-05-24 2012-11-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for prognosing solid tumor outcome
US10575774B2 (en) * 2017-02-27 2020-03-03 Case Western Reserve University Predicting immunotherapy response in non-small cell lung cancer with serial radiomics

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4506009A (en) * 1982-03-30 1985-03-19 University Of California Heterogeneous immunoassay method
EP0378676A4 (en) * 1988-07-15 1991-01-16 The Trustees Of Columbia University In The City Of New York Tumor necrosis enhancing factor and methods of preparation and use
US5147638A (en) * 1988-12-30 1992-09-15 Oklahoma Medical Research Foundation Inhibition of tumor growth by blockade of the protein C system
EP0458903A4 (en) * 1989-02-17 1992-06-17 Codon Soluble analogs of thrombomodulin
US5196404B1 (en) * 1989-08-18 1996-09-10 Biogen Inc Inhibitors of thrombin
ES2193143T3 (es) * 1992-03-05 2003-11-01 Univ Texas Uso de inmunoconjugados para la diagnosis y/o terapia de tumores vascularizaos.
FR2695562B1 (fr) * 1992-09-11 1994-10-14 Synthelabo Utilisation d'un inhibiteur direct de la thrombine pour la fabrication d'un médicament à activité thrombolytique.

Also Published As

Publication number Publication date
FI965008A0 (sv) 1996-12-13
WO1995034319A1 (en) 1995-12-21
ZA954984B (en) 1996-12-17
US5830448A (en) 1998-11-03
DE69524093D1 (de) 2002-01-03
CA2191065A1 (en) 1995-12-21
US5762921A (en) 1998-06-09
AU2821295A (en) 1996-01-05
AU696003B2 (en) 1998-08-27
FI119677B (sv) 2009-02-13
JPH10501813A (ja) 1998-02-17
EP0765168B1 (en) 2001-11-21
IL114119A (en) 2000-09-28
IL114119A0 (en) 1995-10-31
DE69524093T2 (de) 2002-07-11
KR970703783A (ko) 1997-08-09
EP0765168A1 (en) 1997-04-02

Similar Documents

Publication Publication Date Title
FI970918A (sv) Föreningar och förfarande för behandling av cancer
NO20003096D0 (no) Sammensetninger og fremgangsmÕter for behandling av ADD
FI971969A0 (sv) Kompositioner för behandling av hemorrojder och användningsmetod
EE03399B1 (et) Teraapias kasutatavad spiro-asabitsüklilised ühendid ja nende valmistamise protsess
NO984431L (no) FremgangsmÕte for behandling av smerte
DE69518919D1 (de) Autoantikörper enthaltende zusammensetzung für tumorbehandlung und -vorbeugung
DE69526966T2 (de) Hautkräftigende kometische zusammensetzung
DE69513916D1 (de) Oberflächenbehandlungszusammensetzung
DE69603089T2 (de) Zusammensetzung zur behandlung von mauerwerk
EP0758196A4 (en) COMPOSITIONS AND METHODS FOR TREATING TUMORS
FI965008A (sv) Sammansättningar och förfaranden för tumörbehandling
IS4466A (is) Samsetning og meðhöndlun fyrir heila- og mænusigg
FI954773A0 (sv) Antihypertriglyceridemisk sammansättning
DE69520998D1 (de) Faserbehandlungszusammensetzungen
BR9510062A (pt) Macromonômeto esterificado e composição
NO984446D0 (no) FremgangsmÕte for behandling av smerte
FI971138A (sv) Keramiska isolatorer och förfaranden för deras framställning
DE69519913T2 (de) Dauerwellenzusammensetzung
FI954245A0 (sv) Kompositioner och metoder för behandling av immunförmedlade inflammatoriska rubbningar
ATE209195T1 (de) Naphthylverbindungen und zusammensetzungen
BR9505995A (pt) Composto método para tratamentos e composição farmacêutica
NO964485D0 (no) Fremgangsmåte for stabilisering av forbindelsen DX-52-1 og lyofilisert sammensetning derav
FI955123A (sv) Komposition innehållande kolestyramin och förfarande för framställning av densamma
DE69532410D1 (de) Härtbare zusammensetzung
FI970657A0 (sv) Kompositioner och metoder för bekämpning av skadeinsekter

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119677

Country of ref document: FI

MA Patent expired